MedPath

Atenurix

Brand Name: Atenurix

Generic Name: Febuxostat

Active
Registration Number

DR-XY38998

Dosage Form

Film-Coated Tablet

Issuance Date

March 22, 2022

Expiry Date

April 4, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength120mg
PackagingAlu-Alu Blister Pack of 10's. (Box of 30's).

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

FebuxostatActive
Monograph: Febuxostat

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform